Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation
- PMID: 18596271
- DOI: 10.1056/NEJMoa0706873
Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation
Abstract
Background: During the administration of advanced cardiac life support for resuscitation from cardiac arrest, a combination of vasopressin and epinephrine may be more effective than epinephrine or vasopressin alone, but evidence is insufficient to make clinical recommendations.
Methods: In a multicenter study, we randomly assigned adults with out-of-hospital cardiac arrest to receive successive injections of either 1 mg of epinephrine and 40 IU of vasopressin or 1 mg of epinephrine and saline placebo, followed by administration of the same combination of study drugs if spontaneous circulation was not restored and subsequently by additional epinephrine if needed. The primary end point was survival to hospital admission; the secondary end points were return of spontaneous circulation, survival to hospital discharge, good neurologic recovery, and 1-year survival.
Results: A total of 1442 patients were assigned to receive a combination of epinephrine and vasopressin, and 1452 to receive epinephrine alone. The treatment groups had similar baseline characteristics except that there were more men in the group receiving combination therapy than in the group receiving epinephrine alone (P=0.03). There were no significant differences between the combination-therapy and the epinephrine-only groups in survival to hospital admission (20.7% vs. 21.3%; relative risk of death, 1.01; 95% confidence interval [CI], 0.97 to 1.05), return of spontaneous circulation (28.6% vs. 29.5%; relative risk, 1.01; 95% CI, 0.97 to 1.06), survival to hospital discharge (1.7% vs. 2.3%; relative risk, 1.01; 95% CI, 1.00 to 1.02), 1-year survival (1.3% vs. 2.1%; relative risk, 1.01; 95% CI, 1.00 to 1.02), or good neurologic recovery at hospital discharge (37.5% vs. 51.5%; relative risk, 1.29; 95% CI, 0.81 to 2.06).
Conclusions: As compared with epinephrine alone, the combination of vasopressin and epinephrine during advanced cardiac life support for out-of-hospital cardiac arrest does not improve outcome. (ClinicalTrials.gov number, NCT00127907.)
2008 Massachusetts Medical Society
Comment in
-
Vasopressors in cardiopulmonary resuscitation.N Engl J Med. 2008 Oct 9;359(15):1624; author reply 1625. doi: 10.1056/NEJMc081591. N Engl J Med. 2008. PMID: 18843128 No abstract available.
-
Vasopressors in cardiopulmonary resuscitation.N Engl J Med. 2008 Oct 9;359(15):1624-5; author reply 1625. N Engl J Med. 2008. PMID: 18956481 No abstract available.
Similar articles
-
A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.N Engl J Med. 2004 Jan 8;350(2):105-13. doi: 10.1056/NEJMoa025431. N Engl J Med. 2004. PMID: 14711909 Clinical Trial.
-
Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.Arch Intern Med. 2009 Jan 12;169(1):15-24. doi: 10.1001/archinternmed.2008.509. Arch Intern Med. 2009. PMID: 19139319 Clinical Trial.
-
Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest.Am J Cardiol. 2006 Nov 15;98(10):1316-21. doi: 10.1016/j.amjcard.2006.06.022. Epub 2006 Sep 26. Am J Cardiol. 2006. PMID: 17134621 Clinical Trial.
-
Vasopressin or epinephrine for out-of-hospital cardiac arrest.Ann Emerg Med. 2006 Jul;48(1):86-97. doi: 10.1016/j.annemergmed.2005.11.024. Epub 2006 Feb 10. Ann Emerg Med. 2006. PMID: 16781924 Review.
-
New approaches to out-of-hospital cardiac arrest.Mt Sinai J Med. 2006 Jan;73(1):440-8. Mt Sinai J Med. 2006. PMID: 16470324 Review.
Cited by
-
A Narrative Review of Drug Therapy in Adult and Pediatric Cardiac Arrest.Rev Cardiovasc Med. 2023 Jun 6;24(6):163. doi: 10.31083/j.rcm2406163. eCollection 2023 Jun. Rev Cardiovasc Med. 2023. PMID: 39077526 Free PMC article. Review.
-
Mortality, morbidity & clinical outcome with different types of vasopressors in out of hospital cardiac arrest patients- a systematic review and meta-analysis.BMC Cardiovasc Disord. 2024 May 30;24(1):283. doi: 10.1186/s12872-024-03962-4. BMC Cardiovasc Disord. 2024. PMID: 38816786 Free PMC article.
-
Effectiveness of Vasopressin Against Cardiac Arrest: A Systematic Review of Systematic Reviews.Cardiovasc Drugs Ther. 2024 Mar 12. doi: 10.1007/s10557-024-07571-3. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38470507 Review.
-
Therapeutic effects of vasopressin on cardiac arrest: a systematic review and meta-analysis.BMJ Open. 2023 Apr 17;13(4):e065061. doi: 10.1136/bmjopen-2022-065061. BMJ Open. 2023. PMID: 37068900 Free PMC article.
-
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec. J Arrhythm. 2022. PMID: 36524037 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials